These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 17934907

  • 1. The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction.
    Boos CJ, Balakrishnan B, Lip GY.
    Ann Med; 2008; 40(1):66-73. PubMed ID: 17934907
    [Abstract] [Full Text] [Related]

  • 2. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
    Lee KW, Blann AD, Lip GY.
    Int J Cardiol; 2006 Aug 10; 111(2):302-8. PubMed ID: 16324758
    [Abstract] [Full Text] [Related]

  • 3. Circulating endothelial cells in acute ischaemic stroke.
    Nadar SK, Lip GY, Lee KW, Blann AD.
    Thromb Haemost; 2005 Oct 10; 94(4):707-12. PubMed ID: 16270621
    [Abstract] [Full Text] [Related]

  • 4. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY, Freestone B, Lim HS, Kistorp C, Gustafsson F, Hildebrandt P, Lip GY.
    Int J Cardiol; 2007 Jun 25; 119(1):80-2. PubMed ID: 17027106
    [Abstract] [Full Text] [Related]

  • 5. Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease.
    Freestone B, Lip GY, Chong AY, Nadar S, Lee KW, Blann AD.
    Thromb Haemost; 2005 Oct 25; 94(4):702-6. PubMed ID: 16270620
    [Abstract] [Full Text] [Related]

  • 6. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
    Makin AJ, Blann AD, Chung NA, Silverman SH, Lip GY.
    Eur Heart J; 2004 Mar 25; 25(5):371-6. PubMed ID: 15033248
    [Abstract] [Full Text] [Related]

  • 7. The effects of exercise stress testing, diurnal variation and temporal decline on circulating progenitor cells.
    Watson T, Shantsila E, Karthikeyan VJ, Jessani S, Goon PK, Lip GY.
    Thromb Haemost; 2010 Feb 25; 103(2):419-25. PubMed ID: 20126832
    [Abstract] [Full Text] [Related]

  • 8. Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/dysfunction.
    Boos CJ, Balakrishnan B, Jessani S, Blann AD, Lip GY.
    Chest; 2007 Dec 25; 132(6):1920-6. PubMed ID: 18079225
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Short-term high-dose folic acid does not alter markers of endothelial cell damage in patients with coronary heart disease.
    Doshi SN, Moat SJ, Lewis MJ, McDowell IF, Giddings JC, Goodfellow J.
    Int J Cardiol; 2004 Apr 25; 94(2-3):203-7. PubMed ID: 15093982
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction.
    Freestone B, Chong AY, Blann AD, Lip GY.
    Thromb Res; 2006 Apr 25; 118(4):479-85. PubMed ID: 16318868
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY, Freestone B, Patel J, Lim HS, Hughes E, Blann AD, Lip GY.
    Am J Cardiol; 2006 Mar 01; 97(5):671-5. PubMed ID: 16490435
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Varughese GI, Patel JV, Tomson J, Blann AD, Hughes EA, Lip GY.
    J Intern Med; 2007 Apr 01; 261(4):384-91. PubMed ID: 17391113
    [Abstract] [Full Text] [Related]

  • 18. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
    Lee KW, Blann AD, Lip GY.
    Am J Hypertens; 2005 Jan 01; 18(1):104-15. PubMed ID: 15691624
    [Abstract] [Full Text] [Related]

  • 19. Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
    Nadar SK, Al Yemeni E, Blann AD, Lip GY.
    Thromb Res; 2004 Jan 01; 113(2):123-8. PubMed ID: 15115667
    [Abstract] [Full Text] [Related]

  • 20. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG, Martin SC, Felmeden DC, Blann AD, Beevers GD, Lip GY.
    Int J Cardiol; 2004 Apr 01; 94(2-3):293-300. PubMed ID: 15093996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.